MYGN MYRIAD GENETICS INC

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in only 1/4 quarters. Q3 2019: $0M, Q3 2020: $0M, Q3 2018: $0M, Q2 2018: $10M

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $0M vs trailing avg $3M (-100%)

What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.

Negative FCF ($-62M), buybacks not supported by cash flow

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Repurchased 0 shares = 0.0% of 91,300,000 outstanding (annualized)

Are officers and directors buying stock with their own money on the open market?

4 open-market purchases by 2 insiders

• Raha Samraat S. (President and CEO) bought 40,000 shares at $5.00 on 2026-03-09
• Phanstiel S. Louise () bought 48,000 shares at $4.66 on 2026-02-27
• Phanstiel S. Louise () bought 50,407 shares at $4.80 on 2026-02-26
• Phanstiel S. Louise () bought 6,100 shares at $4.74 on 2026-02-25

Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.

4 insider purchases but company buybacks inactive

Over the last 90 days, are insiders net buyers or net sellers on the open market?

Insiders bought $1M, sold $0M in the last 90 days (net buying)

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

No buyback-insider divergence detected